Related Experiment Video

Updated: Aug 12, 2025

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

2.5K

Impact of coronavirus disease 2019 on co-morbidities in HIV

Giovanni Guaraldi1,2,3, Jovana Milic1,2

  • 1Department of Surgical, Medical, Dental and Morphological Sciences.

Current Opinion in HIV and AIDS
|February 1, 2023
PubMed

Insights

People with HIV (PWH) face increasing noninfectious comorbidities and mortality risks in the COVID-19 era. Improved HIV care must integrate patient-centered outcomes, comorbidity screening, and address health inequities.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Gerontology

Background:

  • The COVID-19 pandemic exacerbates existing challenges for people with HIV (PWH).
  • PWH are experiencing a growing burden of noninfectious comorbidities, multimorbidity, and frailty.
  • Current HIV care models may not adequately address these evolving health needs.

Approach:

  • This perspective paper reviews the hypothesized changes in HIV comorbidities.
  • It offers insights into optimizing screening and management strategies for PWH.
  • The review emphasizes a shift towards patient-centered care and addressing systemic issues.

Key Points:

  • PWH face heightened risks of excess disease and mortality due to comorbidities in the COVID-19 era.
  • HIV care must evolve beyond viral suppression to include comprehensive assessments of individual needs and environments.
  • Screening for comorbidities, geriatric syndromes, and addressing stigma, ageism, and access disparities are crucial.

Conclusions:

  • The COVID-19 pandemic widens the gap in healthcare access and unmet needs for PWH.
  • Redesigning care delivery around individual needs, ensuring health equity, and combating stigma are imperative.
  • Future HIV management requires a holistic approach that integrates comorbidity care and promotes health equity.
Abstract

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K
An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

10.4K

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
419
Factors Affecting Illness01:18

Factors Affecting Illness

When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.3K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K